Kuur Therapeutics (formerly known as Cell Medica) is a company that develops CAR-NKT cell therapy to treat cancer. Its technology platform combines a specific subset of T cells, called natural killer T cells (NKT cells), and chimeric antigen receptor (CAR) construct engineering. This approach helps to produce therapies targeting both hematological and solid tumors.